✦ LIBER ✦

Administration of Systemic or Local Interleukin-2 Enhances the Anti-tumor Effects of Interleukin-12 Gene Therapy

✍ Scribed by Itzhak Pappo; Hideaki Tahara; Paul D. Robbins; Maurice K. Gately; Stanley F. Wolf; Amir Barnea; Michael T. Lotze

Book ID: 115634724
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 589 KB
Volume: 58
Category: Article
ISSN: 0022-4804
DOI: 10.1006/jsre.1995.1034

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effectiveness of cancer vaccine therapy

Effectiveness of cancer vaccine therapy using cells transduced with the interleukin-12 gene combined with systemic interleukin-18 administration

✍ Hara, Isao; Nagai, Hiroshi; Miyake, Hideaki; Yamanaka, Kazuki; Hara, Shoji; Mica 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 182 KB

Insertion of interleukin-2 (IL-2) and in

Insertion of interleukin-2 (IL-2) and interleukin-12 (IL-12) genes into vaccinia virus results in effective anti-tumor responses without toxicity

✍ Howard L Kaufman; Ken Flanagan; Christopher S.D Lee; Donato J Perretta; Heidi Ho 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 187 KB

Anti-tumor effects of local irradiation

Anti-tumor effects of local irradiation in combination with peritumoral administration of low doses of recombinant interleukin-2 (rIL-2)

✍ I.-M. Jürgenliemk-Schulz; I.B. Renes; D.H. Rutgers; L.A. Everse; M.R. Bernsen; W 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 208 KB

The aim of this work was to improve radiotherapy results by immune stimulation. We tested the effects of a combination of radio-and immunotherapy, i.e., local low dose recombinant interleukin-2 (rIL-2) treatment, in two murine tumor models. Syngeneic tumors (SL2 lymphoma or M8013 mammary carcinoma)

Anti-tumor activity of interleukin-2-pro

Anti-tumor activity of interleukin-2-producing tumor cells and recombinant interleukin 12 against mouse glioma cells located in the central nervous system

✍ Tetsuro Kikuchi; Tatsuhiro Joki; Saburo Saitoh; Yuichi Hata; Toshiaki Abe; Naoki 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 134 KB 👁 2 views

Interleukin 12 (IL-12) exhibits anti-tumor activity in a variety of laboratory models. Although IL-12 itself activates strong anti-tumor activity, the combination of vaccine therapy with IL-2-transduced tumor cells and systemic rIL-12 has been shown to cure tumor-bearing mice more effectively than e

Systemic administration of interleukin-1

Systemic administration of interleukin-12 can restore the anti-tumor potential of B16 melanoma-draining lymph node cells impaired at a late tumor-bearing state

✍ Mamoru Harada; Koji Tamada; Koichiro Abe; Tieli Li; Yasuhiro Onoe; Hitoshi Tada; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 100 KB

We investigated the effect of the systemic administration of interleukin (IL)-12 on the anti-tumor potential of tumordraining lymph nodes (LNs). Tumor-draining LN cells on day 10 after s.c. inoculation of B16 melanoma showed a significant anti-tumor effect against established pulmonary metastases af

Effective transfer of interleukin-12 gen

Effective transfer of interleukin-12 gene to solid tumors using a novel gene delivery system, poly [D,L-2,4-diaminobutyric acid]

✍ Iwashita, Yukio; Ogawa, Tadashi; Goto, Shigeru; Nakanishi, Masaru; Goto, Takeshi 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 141 KB